Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA

被引:10
作者
Coccaro, Nicoletta [1 ]
Anelli, Luisa [1 ]
Zagaria, Antonella [1 ]
Tarantini, Francesco [1 ]
Cumbo, Cosimo [1 ]
Tota, Giuseppina [1 ]
Minervini, Crescenzio Francesco [1 ]
Minervini, Angela [1 ]
Conserva, Maria Rosa [1 ]
Redavid, Immacolata [1 ]
Parciante, Elisa [1 ]
Macchia, Maria Giovanna [1 ]
Specchia, Giorgina [2 ]
Musto, Pellegrino [1 ]
Albano, Francesco [1 ]
机构
[1] Univ Bari Aldo Moro, Dept Precis & Regenerat Med & Ionian Area DiMePRe, Hematol & Stem Cell Transplantat Unit, I-70124 Bari, Italy
[2] Univ Bari Aldo Moro, Sch Med, I-70124 Bari, Italy
关键词
cytogenetics; hematologic neoplasms; optical genome mapping; CHRONIC LYMPHOCYTIC-LEUKEMIA; STRUCTURAL VARIATION; LYMPHOBLASTIC-LEUKEMIA; MULTIPLE-MYELOMA; STIMULATION; ABERRATIONS; CELLS; CLASSIFICATION; PROLIFERATION; PROGNOSIS;
D O I
10.3390/diagnostics13111841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Optical genome mapping (OGM) is a new genome-wide technology that can reveal both structural genomic variations (SVs) and copy number variations (CNVs) in a single assay. OGM was initially employed to perform genome assembly and genome research, but it is now more widely used to study chromosome aberrations in genetic disorders and in human cancer. One of the most useful OGM applications is in hematological malignancies, where chromosomal rearrangements are frequent and conventional cytogenetic analysis alone is insufficient, necessitating further confirmation using ancillary techniques such as fluorescence in situ hybridization, chromosomal microarrays, or multiple ligation-dependent probe amplification. The first studies tested OGM efficiency and sensitivity for SV and CNV detection, comparing heterogeneous groups of lymphoid and myeloid hematological sample data with those obtained using standard cytogenetic diagnostic tests. Most of the work based on this innovative technology was focused on myelodysplastic syndromes (MDSs), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL), whereas little attention was paid to chronic lymphocytic leukemia (CLL) or multiple myeloma (MM), and none was paid to lymphomas. The studies showed that OGM can now be considered as a highly reliable method, concordant with standard cytogenetic techniques but able to detect novel clinically significant SVs, thus allowing better patient classification, prognostic stratification, and therapeutic choices in hematological malignancies.
引用
收藏
页数:17
相关论文
共 83 条
  • [1] SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes
    Afable, Manuel G., II
    Wlodarski, Marcin
    Makishima, Hideki
    Shaik, Mohammed
    Sekeres, Mikkael A.
    Tiu, Ramon V.
    Kalaycio, Matt
    O'Keefe, Christine L.
    Maciejewski, Jaroslaw P.
    [J]. BLOOD, 2011, 117 (25) : 6876 - 6884
  • [2] Guiding the global evolution of cytogenetic testing for hematologic malignancies
    Akkari, Yassmine M. N.
    Baughn, Linda B.
    Dubuc, Adrian M.
    Smith, Adam C.
    Mallo, Mar
    Dal Cin, Paola
    Diez Campelo, Maria
    Gallego, Marta S.
    Granada Font, Isabel
    Haase, Detlef T.
    Schlegelberger, Brigitte
    Slavutsky, Irma
    Mecucci, Cristina
    Levine, Ross L.
    Hasserjian, Robert P.
    Sole, Francesc
    Levy, Brynn
    Xu, Xinjie
    [J]. BLOOD, 2022, 139 (15) : 2273 - 2284
  • [3] Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia
    Akkari, Yassmine M. N.
    Bruyere, Helene
    Hagelstrom, R. Tanner
    Kanagal-Shamanna, Rashmi
    Liu, Jie
    Luo, Minjie
    Mikhail, Fady M.
    Pitel, Beth A.
    Raca, Gordana
    Shago, Mary
    Shao, Lina
    Smith, Lisa R.
    Smolarek, Teresa A.
    Yenamandra, Ashwini
    Baughn, Linda B.
    [J]. CANCER GENETICS, 2020, 243 : 52 - 72
  • [4] Genome Instability in Multiple Myeloma: Facts and Factors
    Aksenova, Anna Y.
    Zhuk, Anna S.
    Lada, Artem G.
    Zotova, Irina, V
    Stepchenkova, Elena, I
    Kostroma, Ivan I.
    Gritsaev, Sergey, V
    Pavlov, Youri, I
    [J]. CANCERS, 2021, 13 (23)
  • [5] Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements
    Albano, Francesco
    Anelli, Luisa
    Zagaria, Antonella
    Coccaro, Nicoletta
    Casieri, Paola
    Rossi, Antonella Russo
    Vicari, Laura
    Liso, Vincenzo
    Rocchi, Mariano
    Specchia, Giorgina
    [J]. MOLECULAR CANCER, 2010, 9
  • [6] International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert P.
    Borowitz, Michael J.
    Calvo, Katherine R.
    Kvasnicka, Hans-Michael
    Wang, Sa A.
    Bagg, Adam
    Barbui, Tiziano
    Branford, Susan
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    Dal Cin, Paola
    DiNardo, Courtney D.
    Dombret, Herve
    Duncavage, Eric J.
    Ebert, Benjamin L.
    Estey, Elihu H.
    Facchetti, Fabio
    Foucar, Kathryn
    Gangat, Naseema
    Gianelli, Umberto
    Godley, Lucy A.
    Gokbuget, Nicola
    Gotlib, Jason
    Hellstrom-Lindberg, Eva
    Hobbs, Gabriela S.
    Hoffman, Ronald
    Jabbour, Elias J.
    Kiladjian, Jean-Jacques
    Larson, Richard A.
    Le Beau, Michelle M.
    Loh, Mignon L. -C.
    Lowenberg, Bob
    Macintyre, Elizabeth
    Malcovati, Luca
    Mullighan, Charles G.
    Niemeyer, Charlotte
    Odenike, Olatoyosi M.
    Ogawa, Seishi
    Orfao, Alberto
    Papaemmanuil, Elli
    Passamonti, Francesco
    Porkka, Kimmo
    Pui, Ching-Hon
    Radich, Jerald P.
    Reiter, Andreas
    Rozman, Maria
    Rudelius, Martina
    Savona, Michael R.
    [J]. BLOOD, 2022, 140 (11) : 1200 - 1228
  • [7] Single Nucleotide Polymorphism Array Karyotyping: A Diagnostic and Prognostic Tool in Myelodysplastic Syndromes with Unsuccessful Conventional Cytogenetic Testing
    Arenillas, Leonor
    Mallo, Mar
    Ramos, Fernando
    Guinta, Kathryn
    Barragan, Eva
    Lumbreras, Eva
    Larrayoz, Maria-Jose
    De Paz, Raquel
    Tormo, Mar
    Abaigar, Maria
    Pedro, Carme
    Cervera, Jose
    Such, Esperanza
    Jose Calasanz, Maria
    Diez-Campelo, Maria
    Sanz, Guillermo F.
    Maria Hernandez, Jesus
    Luno, Elisa
    Saumell, Silvia
    Maciejewski, Jaroslaw
    Florensa, Lourdes
    Sole, Francesc
    [J]. GENES CHROMOSOMES & CANCER, 2013, 52 (12) : 1167 - 1177
  • [8] Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
    Balducci, Estelle
    Kaltenbach, Sophie
    Villarese, Patrick
    Duroyon, Eugenie
    Zalmai, Loria
    Friedrich, Chloe
    Suarez, Felipe
    Marcais, Ambroise
    Bouscary, Didier
    Decroocq, Justine
    Birsen, Rudy
    Fontenay, Michaela
    Temple, Marie
    Brouzes, Chantal
    Touzart, Aurore
    Steimle, Thomas
    Cieslak, Agata
    Lhermitte, Ludovic
    Almire, Carole
    Chapuis, Nicolas
    Hermine, Olivier
    Asnafi, Vahid
    Kosmider, Olivier
    Couronne, Lucile
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (09)
  • [9] Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
    Baliakas, Panagiotis
    Jeromin, Sabine
    Iskas, Michalis
    Puiggros, Anna
    Plevova, Karla
    Nguyen-Khac, Florence
    Davis, Zadie
    Rigolin, Gian Matteo
    Visentin, Andrea
    Xochelli, Aliki
    Delgado, Julio
    Baran-Marszak, Fanny
    Stalika, Evangelia
    Abrisqueta, Pau
    Durechova, Kristina
    Papaioannou, George
    Eclache, Virginie
    Dimou, Maria
    Iliakis, Theodoros
    Collado, Rosa
    Doubek, Michael
    Jose Calasanz, M.
    Ruiz-Xiville, Neus
    Moreno, Carolina
    Jarosova, Marie
    Leeksma, Alexander C.
    Panayiotidis, Panayiotis
    Podgornik, Helena
    Cymbalista, Florence
    Anagnostopoulos, Achilles
    Trentin, Livio
    Stavroyianni, Niki
    Davi, Fred
    Ghia, Paolo
    Kater, Arnon P.
    Cuneo, Antonio
    Pospisilova, Sarka
    Espinet, Blanca
    Athanasiadou, Anastasia
    Oscier, David
    Haferlach, Claudia
    Stamatopoulos, Kostas
    [J]. BLOOD, 2019, 133 (11) : 1205 - 1216
  • [10] Extramedullary multiple myeloma
    Bhutani, Manisha
    Foureau, David M.
    Atrash, Shebli
    Voorhees, Peter M.
    Usmani, Saad Z.
    [J]. LEUKEMIA, 2020, 34 (01) : 1 - 20